Ted Agres | Oct 1, 2001 | 4 min read
If research involving human embryonic stem cells (ESCs) is to achieve its potential for creating breakthrough medical therapies, additional new cell lines should be created, and therapeutic cloning--or somatic cell nuclear transfer (SCNT)--should be employed, according to an expert panel of the National Academy of Sciences. Both of these views are strongly opposed by the Bush administration, and the US House of Representatives has voted to outlaw human SCNT techniques by public and private resea